KRT8P33: A Potential Drug Target and Biomarker (G100418737)

Target Name: KRT8P33

NCBI ID: G100418737

KRT8P33

Other Name(s): Keratin 8 pseudogene 33 | keratin 8 pseudogene 33

KRT8P33: A Potential Drug Target and Biomarker

Kallikrein-related peptidases (KRTs) are a family of enzymes that regulate proteolytic enzymes, which are responsible for breaking down other proteins. KRTs play a crucial role in maintaining cellular homeostasis, and their dysfunction has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The KRT8 family consists of eight different isoforms, including KRT8.0, KRT8.1, KRT8.2, KRT8.3, KRT8.4, KRT8.5, KRT8.6, and KRT8.7. These isoforms differ in their catalytic activity, with KRT8.0 and KRT8.1 being the most potent, while KRT8.7 is the least potent.

KRT8P33 is a potential drug target and biomarker for several reasons. First, it is a highly conserved protein, with significant sequence identity to other KRTs. Second, it has been shown to play a role in a number of cellular processes, including cell signaling, cell adhesion, and tissue repair. Third, KRT8P33 has been shown to be involved in the regulation of cellular processes that are associated with cancer, such as cell proliferation, migration, and invasion.

Furthermore, KRT8P33 has also been shown to be involved in the regulation of pain perception and neuroinflammation. Its expression has been shown to be elevated in the brains of individuals with chronic pain, and its inhibition has been shown to alleviate pain in animal models of pain. Additionally, KRT8P33 has also been shown to play a role in the regulation of inflammation, with its inhibition having been shown to reduce neuroinflammation in animal models of inflammation.

In addition to its potential clinical applications, KRT8P33 also has potential as a biomarker for a number of diseases. Its expression has been shown to be elevated in a number of diseases, including neurodegenerative diseases, cancer, and autoimmune disorders. Additionally, its inhibition has been shown to protect against the development and progression of these diseases.

In conclusion, KRT8P33 is a promising drug target and biomarker for a number of diseases. Its conservation in sequence and its involvement in cellular processes that are associated with disease make it a promising candidate for further investigation. Additionally, its potential as a biomarker for a number of diseases makes it an important target for future research.

Note: The above article is for educational purposes only and should not be taken as medical advice.

Protein Name: Keratin 8 Pseudogene 33

The "KRT8P33 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT8P33 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets